Press Releases

Results of the 2026 Annual General Meeting for the 2024/25 financial year of BRAIN Biotech AG

BRAIN Biotech announces 3M 25/26 results and breakthrough at BioIncubator company SolasCure: Aurase® Wound Gel showing strong clinical evidence of superior debridement and healing in chronic wounds

FY 2024/25: BRAIN Biotech AG benefits from successful monetization of projects and strong corporate cost control

BRAIN Biotech AG appoints Johan Jansén-Storbacka as Executive Vice President of the BRAINBiocatalysts´ enzyme products business

BRAIN Biotech reports dynamic Q3 revenue growth in core segment BRAINBiocatalysts

Corbion and BRAIN Biotech team to shape the future of innovation in nature-based ingredient technologies

Experienced biotechnology expert joins the Supervisory Board of BRAIN Biotech AG

BRAIN Biotech AG reports final half-year figures for fiscal year 2024/25

BRAIN Biotech announces buy-out of minorities, new continental European production site, and expansion of its Baking Application Center